Beranda › Pendarahan › Missouri
Uji klinis Pendarahan di Missouri
8 studi untuk Pendarahan mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
- University of Missouri Health Care, Columbia
Menerima pesertaFase 2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05958342A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318Auricular VNS Following Intracerebral Hemorrhage
- Washington University School of Medicine, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06799390A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
- Washington University, St Louis
Menerima pesertaFase 3
1 Month · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06664775Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Mid America Health Institute, Kansas City
- Washington University School of Medicine, St Louis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04045665Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Children's Hospital St. Louis, St Louis
Menerima pesertaFase 2/3
Hingga usia 17 · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT04924322Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
- Washington University School of Medicine, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Okt 2025 · NCT07219108Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.